When extended-release methylphenidate underperforms: three children with ADHD and gastrointestinal disease
Methylphenidate (MPH) is the first-line pharmacological treatment for attention-deficit/hyperactivity disorder (ADHD) in children, available in immediate-release (IR) and extended-release (ER) formulations with distinct release profiles. Whether gastrointestinal pathology might selectively…
Suggested reading